(1S,2R)-2-methylcyclopropane-1-carboxylic acid

Catalog No.: 
ACLASW453
CAS No.: 
26510-98-5
Molecular Formula: 
C5H8O2
Molecular Weight: 
100.12
(1S,2R)-2-methylcyclopropane-1-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$219.00In stockIn stock
250mg97%$329.00In stockIn stock
1g97%$740.00In stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1S,2R)-2-methylcyclopropane-1-carboxylic acid
IUPAC Name(1S,2R)-2-methylcyclopropane-1-carboxylic acid
MDL No.MFCD19238068
Molecular FormulaC5H8O2
Molecular Weight100.12
SMILESO=C([C@H]1[C@@H](C)C1)O
InChI KeyAYEGPMGNMOIHDL-DMTCNVIQSA-N
SynonymSCHEMBL5521450 | PS-15486 | (1S,2R)-2-methylcyclopropanecarboxylic acid | Cyclopropanecarboxylic acid, 2-methyl-, (1S-cis)- | EN300-2513560 | MFCD19238068 | EN300-1589186 | P12613 | (1S,2R)-2-methylcyclopropane-1-carboxylic acid | (1S,2R)-2-methylcyclopro
CAS No.26510-98-5
PubChem CID6995701

Safety Data

Pictogram
Corrosive
Signal Word
Danger
Hazard Statement(s)
H314
Precautionary Statement(s)
P260-P264-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P363-P405-P501

Synthetic Route by SureRoute

1. ACLASW453 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLASW453 route product structure diagram
    ACLASW45326510-98-5In Stock
Inquiry

2. ACLASW453 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLASW453 route product structure diagram
    ACLASW45326510-98-5In Stock
Inquiry

3. ACLASW453 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLASW453 route product structure diagram
    ACLASW45326510-98-5In Stock
Inquiry

Comments (0)